Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
House of Jane, Inc. (OTC: HOJI) is a publicly traded company associated with the cannabis and cannabinoid consumer products sector. Public disclosures indicate that the company has focused on developing, marketing, and distributing hemp-derived and cannabis-related wellness products, including cannabidiol (CBD) consumer offerings. Available filings and market disclosures suggest the company has pursued opportunities tied to lifestyle branding, wellness, and alternative consumer packaged goods markets, though the scope of active operations has varied over time.
Historically, the company appears to have evolved through restructuring activity and strategic repositioning common among smaller OTC-listed issuers operating in emerging cannabis-related industries. Publicly available information regarding revenue scale, sustained commercial operations, and long-term operating performance is limited and in some cases inconsistent across filings and market databases. Data inconclusive based on available public sources regarding the company’s current operational scale and market share.
Business Operations
Public filings and market disclosures indicate that House of Jane, Inc. has operated through cannabis- and hemp-related product development and brand commercialization activities. Reported business efforts have included consumer wellness products, cannabinoid formulations, and related branding initiatives targeting retail and wellness-oriented customer segments. The company’s revenue generation strategy has historically centered on product sales, licensing opportunities, and strategic partnerships within the broader cannabis ecosystem.
Available information suggests that operations have primarily been U.S.-focused, with emphasis on states and jurisdictions permitting hemp-derived or cannabis-adjacent consumer products. Publicly disclosed information regarding owned production facilities, proprietary technology platforms, large-scale manufacturing assets, or material international subsidiaries remains limited. Data inconclusive based on available public sources regarding significant joint ventures, large institutional partnerships, or major operating subsidiaries currently contributing material revenue.
Strategic Position & Investments
Strategically, House of Jane, Inc. appears to have aligned itself with growth themes tied to cannabinoid wellness products, consumer branding, and emerging alternative health markets. Like many micro-cap cannabis-sector issuers, the company has historically pursued positioning opportunities linked to evolving U.S. regulatory frameworks surrounding hemp-derived products and CBD commercialization. Public disclosures indicate periodic corporate restructuring and capital market activity intended to support operational continuity and future expansion initiatives.
There is limited verified public information regarding major acquisitions, large-scale capital investments, or ownership stakes in significant portfolio companies. Available records do not clearly establish substantial institutional investment activity or materially transformative mergers. Data inconclusive based on available public sources regarding active investments in advanced cannabis technologies, pharmaceutical cannabinoid research, or internationally scaled cannabis infrastructure.
Geographic Footprint
Public information indicates that House of Jane, Inc. has primarily maintained operations within the United States, with activity concentrated in jurisdictions supportive of hemp-derived wellness and cannabinoid consumer products. The company’s headquarters location and operational footprint have shifted over time in connection with broader corporate restructuring and strategic repositioning efforts reflected in public disclosures.
There is no consistently verified evidence of a substantial multinational operating footprint across Europe, Asia-Pacific, Latin America, or Africa. While the company may have explored broader market opportunities associated with global cannabinoid demand trends, publicly available records do not confirm large-scale international operations, manufacturing networks, or overseas subsidiaries. Data inconclusive based on available public sources regarding material international revenue contribution.
Leadership & Governance
Publicly available information regarding the leadership structure of House of Jane, Inc. is limited and has changed over time. OTC-listed micro-cap issuers frequently experience executive transitions, restructuring events, and governance updates that may not be consistently reflected across third-party databases. As a result, some executive and board information could not be independently verified through multiple current public sources.
Known or previously disclosed leadership associated with the company includes:
- M. David Peterson – Former executive leadership association reported in public market disclosures
- Data inconclusive based on available public sources regarding the company’s current full executive leadership team and active board composition
The company’s publicly communicated strategic direction has generally emphasized participation in the evolving cannabis and hemp consumer products market, with focus areas including wellness branding, cannabinoid product commercialization, and capital market positioning within the emerging cannabis sector.